CSIMarket
 
Hookipa Pharma inc   (NASDAQ: HOOK)
Other Ticker:  
 
 
Price: $1.8035 $0.02 1.320%
Day's High: $1.81 Week Perf: -4.07 %
Day's Low: $ 1.77 30 Day Perf: -3.04 %
Volume (M): 3 52 Wk High: $ 10.50
Volume (M$): $ 6 52 Wk Avg: $5.32
Open: $1.77 52 Wk Low: $1.72



 Market Capitalization (Millions $) 23
 Shares Outstanding (Millions) 13
 Employees 20
 Revenues (TTM) (Millions $) 50
 Net Income (TTM) (Millions $) -43
 Cash Flow (TTM) (Millions $) -48
 Capital Exp. (TTM) (Millions $) 1

Hookipa Pharma Inc
Hookipa Pharma Inc is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immunotherapeutics for cancer and infectious diseases. The company is known for its proprietary technology platform, Vaxwave', which is designed to stimulate both the innate and adaptive immune systems. Hookipa Pharma's goal is to create a new class of immunotherapeutics that are safer and more effective than traditional approaches. The company is headquartered in New York, United States.


   Company Address: 350 Fifth Avenue, 72nd Floor, Suite 7240 New York 10118 NY
   Company Phone Number: 890 63 60   Stock Exchange / Ticker: NASDAQ HOOK


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BMY   -7.48%    
JNJ   -0.57%    
LLY        4.74% 
MRK   -3.6%    
OGN   -0.23%    
REGN        6.47% 
• View Complete Report
   



Merger and Acquisition

Understanding Hookipa Pharma: Implications of Recent UK Disclosure Requirements and Market Regulations

Published Fri, Jan 10 2025 7:00 AM UTC

Understanding Hookipa Pharma: Implications of Recent U.K. Disclosure Requirements and Market RegulationsAs the pharmaceutical landscape continues to evolve, companies must navigate complex regulatory frameworks, particularly when considering cross-border operations and shareholders. HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company specializing in the development of innovative ...

Merger and Acquisition

Hookipa Pharma Reports Strategic Developments Amid UK Disclosure Compliance and Promising Market Outlook

Published Wed, Jan 8 2025 4:23 PM UTC

Breaking News: Hookipa Pharma Navigates UK Disclosure Regulations as Market Antici...

Stock Market Announcement

HOOKIPA Pharma Announce Key U.K. Disclosure Requirements: Implications for Shareholders and Market Performance

Published Tue, Jan 7 2025 9:05 PM UTC

In a recent press release dated January 7, 2025, HOOKIPA Pharma Inc. (NASDAQ: HOOK) informed shareholders about important updates regarding U.K. disclosure requirements. As a clinical-stage biopharmaceutical company specializing in next-generation immunotherapeutics, HOOKIPA is currently focused on innovative treatments for cancer and serious infectious diseases. Key Facts ...

Merger and Acquisition

Potential Merger: Poolbeg and HOOKIPA Pharma Explore Strategic Combination Amid Struggling Share Prices

Published Tue, Jan 7 2025 7:00 AM UTC

The Landscape of Pharmaceutical Innovation: An Important Update on Poolbeg Pharma plc and HOOKIPA Pharma Inc.In the fast-paced world of biopharmaceuticals, strategic partnerships and potential mergers can significantly shape the landscape, offering companies new avenues for growth, innovation, and market penetration. Recently, Poolbeg Pharma plc (Poolbeg) and HOOKIPA Pharma ...

Merger and Acquisition

HOOKIPA Pharma Inc. and Poolbeg Pharma Set to Revolutionize Biotech: A Strategic Collaboration Announcement,

Published Mon, Jan 6 2025 7:00 AM UTC

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.Innovative Pathways: HOOKIPA Pharma Inc. and Poolbeg Pharma Unite to Transform Biotech LandscapeAs the biotech sector continues to evolve at an incredible pace, two players, HOO...







Hookipa Pharma Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com